• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Eye Injury (1845); Visual Disturbances (2140); Eye Pain (4467)
Date of Event 10/18/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lens was returned positioned incorrectly in the lens case.Blood and solution was dried on the lens.One haptic was broken in the gusset area (not returned).Complaint history and product history records were reviewed and documentation indicated the product met release criteria.The file indicated the use of a qualified cartridge and viscoelastic.The associated handpiece was not provided.It is unknown if a qualified product was used.The reported broken haptic was observed.All lenses are 100% inspected for cosmetic attributes and the damage exhibited by the returned complaint sample would not have met companies release criteria.Based on our observation, and the review of manufacturing records, it can be reasonably concluded that the damage is not manufacturing related.Due to the presence of blood, surgical solution, and the condition of the returned sample, the damage is most likely related to customer handling.Information was provided that the health care professional (hcp) "had to enlarge wound to remove and replace lens.This also causes increased astigmatism so the vision is not as clear but hopefully this will correct when i remove suture in six weeks".There are no other complaints in this lot.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non health care professional reported that during the cataract surgery with intraocular lens implant procedure, the lens found to be cracked 2/3 of the lens.Noticed during iol implantation while unfolding in eye.The iol was explanted from the patient and back up lens was implanted during the initial procedure.Additional information received and stated that, left eye was more painful post op as surgeon had to enlarge wound to remove and replace lens.This also causes increased astigmatism so the vision is not as clear but hopefully this will correct when i remove suture in six weeks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key15891780
Report Number1119421-2022-02530
Device Sequence Number6699411
Product Code POE
UDI-Device Identifier00380652421232
UDI-Public00380652421232
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 12/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/26/2026
Device Model NumberDFT015
Device Lot Number15274254
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/18/2022
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/02/2022
Initial Report FDA Received Date12/01/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/28/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; PROVISC OPHTHALMIC VISCOSURGICAL DEVICE
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-